Aptamer Group plc announced the appointment of Derek Smith as interim chief commercial officer, effective as of 1 January 2023. Derek joined the company in 2018 as Director of Global Sales and has since become a vital part of the Aptamer team, overseeing the development and implementation of the Company's global sales strategy and securing contracts across all three business divisions, including with a number of major pharmaceutical companies. Prior to joining Aptamer Group, Derek held senior sales positions at various UK healthcare companies.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6 GBX | -7.69% |
|
-14.29% | -47.83% |
08/07 | Aptamer says annual revenue halves but hails progress with Unilever | AN |
08/07 | Aptamer Says Unilever to Perform In-person Functionality Tests for Optimer Binders | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-47.83% | 3.94M | |
-5.50% | 30.25B | |
+40.35% | 9.47B | |
+31.81% | 4.33B | |
-36.88% | 2.49B | |
-6.48% | 1.66B | |
-23.84% | 1.27B | |
-42.92% | 972M | |
-3.96% | 885M | |
-50.69% | 687M |
- Stock Market
- Equities
- APTA Stock
- News Aptamer Group plc
- Aptamer Group plc Appoints Derek Smith as Interim Chief Commercial Officer